New clinical trials are underway in the Democratic Republic of Congo to test novel therapies against the Bundibugyo Ebola virus, a strain for which no approved vaccines or treatments currently exist. The trials will evaluate two drugs, MBP-134 and remdesivir, both individually and in combination, for their efficacy in treating infected individuals. Additionally, a separate trial will assess the effectiveness of the oral antiviral obeldesivir as a post-exposure prophylactic to prevent infection in those exposed to the virus. AI
RANK_REASON Clinical trials for new drug therapies against a specific virus strain. [lever_c_demoted from research: ic=1 ai=0.0]
- Bundibugyo
- COVID-19
- Democratic Republic of the Congo
- hepatitis C
- Marburg
- MBP-134
- obeldesivir
- remdesivir
- Zaire ebolavirus
AI-generated summary · Google Gemini · from 1 sources. How we write summaries →
